A topical ointment of 1% propranolol at least partially cleared superficial infantile hemangiomas in 90% of patients, a small retrospective review found. No major side effects were observed.
Published in Brief:
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan